CORREVIO PHARMA CORP's ticker is CORV and the CUSIP is 22026V105.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $71,000 | +31.5% | 183,872 | +38.8% | 0.00% | – |
| Q4 2019 | $54,000 | +100.0% | 132,429 | +888.3% | 0.00% | – |
| Q3 2019 | $27,000 | -72.4% | 13,400 | -70.3% | 0.00% | – |
| Q2 2019 | $98,000 | -15.5% | 45,091 | +22.8% | 0.00% | – |
| Q1 2019 | $116,000 | +205.3% | 36,714 | +141.6% | 0.00% | – |
| Q4 2018 | $38,000 | -64.5% | 15,199 | -42.9% | 0.00% | – |
| Q3 2018 | $107,000 | – | 26,605 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|